Omega-3 Labels Need Two Numbers

by | Sep 24, 2026 | noggin notes | 0 comments

A bottle that says “1,000 mg fish oil” looks straightforward. It is not.

That number often describes the total amount of oil in a serving, not the amount of the two omega-3 fats people usually mean when they buy it: EPA and DHA.

This is a small label-reading issue with a larger brain-health lesson. A plausible ingredient is not the same thing as a demonstrated outcome. And a large number on the front of a bottle is not necessarily the number that answers the question you are trying to ask.

Why omega-3s belong in a brain-health conversation

DHA is a structural component of cell membranes, including in the brain. EPA and DHA also participate in signaling pathways involved in many biological processes. That makes omega-3 fats biologically relevant.

But biological relevance is not a guarantee that an omega-3 supplement will improve memory, prevent cognitive decline, or meaningfully change mood for any given person.

Observational research has often found that people who eat more fish have better cognitive outcomes over time. That is useful information, but it cannot isolate omega-3 intake from the rest of a person’s diet, health, income, activity, or social habits.

Randomized trials give us a more direct test of supplements. In generally healthy older adults, those trials have not shown a consistent cognitive benefit from EPA and DHA supplements. Evidence in mild cognitive impairment is more tentative, with some small studies suggesting possible benefit in selected outcomes, but the question remains unsettled.

That distinction matters. “Omega-3s are found in brain tissue” and “an omega-3 capsule protects the brain” are not interchangeable statements.

The number to find on the label

Turn the bottle around and look at the Supplement Facts panel. For fish, krill, or algae oil products, locate the individual amounts of EPA and DHA.

A product may contain 1,000 mg of fish oil while providing a much smaller combined amount of EPA and DHA. Another product with a less dramatic front-label number may provide more EPA and DHA per serving.

This is not an argument that one number is universally ideal. It is an argument for knowing what the number represents.

It can also help to notice the serving size. Sometimes the listed amounts apply to two capsules, not one. “Per serving” is not the same as “per capsule.”

EPA, DHA, ALA: similar family, different questions

EPA and DHA are long-chain omega-3 fats found primarily in seafood and marine-algae sources. Alpha-linolenic acid, or ALA, is another omega-3 fat found in foods such as flax, chia, walnuts, and some oils.

ALA is important nutritionally. The body can convert some ALA into EPA and DHA, but that conversion is limited and variable. So a label that highlights “omega-3” without showing which form it contains leaves an important question unanswered.

For a plant-based product, algae oil can provide DHA, EPA, or both. It is not simply “fish oil for people who do not eat fish.” The useful question is still the same: what does this particular product provide, and what outcome is being implied?

What the evidence does not let us conclude

It is tempting to treat omega-3 supplementation as an insurance policy for the brain. The research does not support that level of certainty.

It also does not support dismissing food sources because a supplement study was neutral. Eating fish is a dietary pattern question. Taking isolated EPA and DHA is a supplement question. Those exposures overlap, but they are not identical.

Then there is marketing language. A statement that a product “supports brain health” is generally a structure or function claim, not proof that it prevents dementia, improves focus, or treats depression. FDA-qualified health claims about EPA and DHA and cardiovascular risk are required to acknowledge that the evidence is inconsistent and inconclusive. That is a useful reminder to read qualifying language, not just the headline.

Questions worth bringing to the label

  • How much EPA does one serving contain?
  • How much DHA does one serving contain?
  • Is the prominent number describing total oil, total omega-3s, or EPA plus DHA?
  • Is the product fish-, krill-, or algae-based?
  • Does the company make a specific outcome claim that goes beyond what the evidence can establish?
  • Is there credible independent testing for identity, contaminants, and label accuracy? Testing can improve confidence in product quality, but it does not prove clinical benefit.

Those questions are more useful than asking whether omega-3s are “good” or “bad” for the brain. They move us from category thinking to evidence thinking.

Before you add it

Omega-3 supplements can have pharmacologic effects and may interact with prescription medications, over-the-counter medications, or medical conditions.

The most relevant concern is with anticoagulant and antiplatelet medications, including warfarin. Available evidence does not show that typical fish-oil use routinely causes clinically significant bleeding, but higher-dose products and concurrent blood-thinning medications deserve review because monitoring may be appropriate. High-dose omega-3 treatment, around 4 grams per day in large trials, was also associated with a small increase in atrial fibrillation among people with cardiovascular disease or elevated cardiovascular risk.

People with a fish or shellfish allergy should examine the source and allergen information carefully. Pregnancy, breastfeeding, bleeding disorders, a history of atrial fibrillation, planned surgery, and use of prescription lipid-lowering therapy are also situations where the formulation and purpose of a product matter.

The better question is not, “Should everyone take omega-3s?” It is, “What is in this product, what outcome am I assuming it will change, and does the evidence support that assumption?”

Written for Dr. Teralyn Sell, PhD
Psychology · Brain Health · Human Behavior

Sources worth knowing

Submit a Comment